by DRG International | Sep 30, 2020 | News, Products |
Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis Context: Severe energy deprivation markedly inhibits erythropoiesis by restricting iron availability for hemoglobin synthesis. Objective:...
by DRG International | Sep 24, 2020 | News, Products |
Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children See full study: https://iopscience.iop.org/article/10.1088/1742-6596/1246/1/012023/meta Abstract Chronic kidney disease (CKD) may present with anemia of chronic disease (ACD),...
by DRG International | Sep 16, 2020 | Products |
Importance of Studying the Levels of Hepcidin & Vitamin D in Egyptian Children with Chronic Hepatitis C See complete study: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463826/ Background and Objective Hepcidin is the key regulator of iron metabolism and is a...
by DRG International | Jul 16, 2020 | News, Products |
DRG is proud to announce the launch of two new Anti-Müllerian Hormone (AMH) assays: AMH ELISA (EIA-6141) AMH DRG HYBRiD XL® (HYE-5770) Clinical Application: AMH has been identified as a reliable marker of ovarian reserve that can help predict early ovarian...
by DRG International | May 25, 2020 | News |
Sales and Business Development Manager, North America Our Company DRG International, Inc. (DRG) is a specialty diagnostic and medical device equipment manufacturer and distributor founded in 1970. The company is privately held and headquartered in central New Jersey...
